Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remarks | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,789 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 9,514 · Balance 63,789 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 5, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 9,514 | $188.88 | $1,797,042.38 |
DisclosureSEC source: 0001214659-26-012546 · marketforms-74094.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,789 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 21, 2026 Filed Sep 23, 2026 20:08 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 348 | $165.49 | $57,590.87 |
DisclosureSEC source: 0001214659-26-011917 · marketforms-74029.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,303 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 412 | $122.62 | $50,521.09 |
DisclosureSEC source: 0001214659-26-011558 · marketforms-73970.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,651 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,598 | $139.07 | $222,227.47 |
DisclosureSEC source: 0001214659-26-010832 · marketforms-73876.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,063 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 14,205 | $129.75 | $1,843,098.75 |
DisclosureSEC source: 0001214659-26-010723 · marketforms-73813.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,661 F1 · shares: The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 14,205 | $109.75 | $1,558,998.75 |
DisclosureSEC source: 0001214659-26-009768 · marketforms-73737.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,866 F1 · shares: The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,070 | $85.32 | $91,293.68 |
DisclosureSEC source: 0001214659-26-009653 · marketforms-73656.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,071 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 14,205 | $89.75 | $1,274,898.75 |
DisclosureSEC source: 0001214659-26-007793 · marketforms-73465.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,141 F1 · shares: The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 17, 2026. Read SEC document |
| June 22, 2026 Filed Jun 24, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 346 | $87.32 | $30,213.55 |
DisclosureSEC source: 0001214659-26-007693 · marketforms-73445.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,346 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 402 | $69.84 | $28,077.37 |
DisclosureSEC source: 0001214659-26-007318 · marketforms-73367.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,692 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 14,205 | $69.75 | $990,798.75 |
DisclosureSEC source: 0001214659-26-007030 · marketforms-73320.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,094 F1 · shares: The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 7, 2025. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,642 | $53.26 | $87,447.99 |
DisclosureSEC source: 0001214659-26-006709 · marketforms-73240.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,299 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,962 | $57.15 | $112,125.95 |
DisclosureSEC source: 0001214659-26-005676 · marketforms-73053.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,941 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 20, 2026 Filed Mar 24, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 354 | $43.79 | $15,500.39 |
DisclosureSEC source: 0001214659-26-003723 · marketforms-72711.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,903 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 425 | $46.43 | $19,731.05 |
DisclosureSEC source: 0001214659-26-003065 · marketforms-72431.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,257 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 844 | $46.71 | $39,423.07 |
DisclosureSEC source: 0001214659-26-002446 · marketforms-72307.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,682 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $49.93 | $249,650.00 |
DisclosureSEC source: 0001214659-26-001724 · marketforms-72117.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,581 F1 · shares: The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 7, 2025. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,099 | $46.58 | $51,187.02 |
DisclosureSEC source: 0001214659-26-001236 · marketforms-72014.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,581 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 324 | $34.56 | $11,196.14 |
DisclosureSEC source: 0001214659-25-018402 · marketforms-71691.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,680 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 398 | $32.88 | $13,085.44 |
DisclosureSEC source: 0001214659-25-017850 · marketforms-71488.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,004 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 757 | $26.50 | $20,063.15 |
DisclosureSEC source: 0001214659-25-017222 · marketforms-71342.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,402 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 25,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-016999 · marketforms-71307.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,159 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2025 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,019 | $32.08 | $32,688.91 |
DisclosureSEC source: 0001214659-25-015974 · marketforms-71200.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,694 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,515 | $31.44 | $204,859.61 |
DisclosureSEC source: 0001214659-25-015767 · marketforms-71183.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,713 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 29,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-015586 · marketforms-71169.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,228 F1 · shares: Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,876 | $32.19 | $124,756.81 |
DisclosureSEC source: 0001214659-25-014772 · marketforms-70956.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,710 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 02, 2025 Filed Oct 6, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 124 | $29.16 | $3,615.96 |
DisclosureSEC source: 0001214659-25-014667 · marketforms-70938.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,586 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:07 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 233 | $27.56 | $6,421.48 |
DisclosureSEC source: 0001214659-25-014123 · marketforms-70833.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,710 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 13:38 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 94 | $25.33 | $2,380.83 |
DisclosureSEC source: 0001214659-25-013842 · marketforms-70787.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,943 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 13:13 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 269 | $25.76 | $6,929.44 |
DisclosureSEC source: 0001214659-25-013568 · marketforms-70708.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,037 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 521 | $25.96 | $13,527.24 |
DisclosureSEC source: 0001214659-25-012704 · marketforms-70337.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,306 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 785 | $28.36 | $22,265.74 |
DisclosureSEC source: 0001214659-25-011608 · marketforms-70152.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,827 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| July 02, 2025 Filed Jul 7, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 125 | $36.19 | $4,524.13 |
DisclosureSEC source: 0001214659-25-010086 · marketforms-70055.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,612 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 230 | $35.76 | $8,223.65 |
DisclosureSEC source: 0001214659-25-009547 · marketforms-69974.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,737 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 94 | $33.48 | $3,146.65 |
DisclosureSEC source: 0001214659-25-009354 · marketforms-69948.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,967 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 257 | $31.75 | $8,159.75 |
DisclosureSEC source: 0001214659-25-009063 · marketforms-69847.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,061 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 531 | $29.75 | $15,795.66 |
DisclosureSEC source: 0001214659-25-008301 · marketforms-69623.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,318 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,000 | $32.72 | $163,590.00 |
DisclosureSEC source: 0001214659-25-007287 · marketforms-69385.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,849 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $32.71 to $32.755 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 689 | $37.65 | $25,941.54 |
DisclosureSEC source: 0001214659-25-007104 · marketforms-69367.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,849 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| April 02, 2025 Filed Apr 4, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 124 | $38.73 | $4,802.89 |
DisclosureSEC source: 0001214659-25-005460 · marketforms-69098.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,538 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 230 | $41.68 | $9,585.48 |
DisclosureSEC source: 0001214659-25-004684 · marketforms-68883.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,662 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 92 | $40.05 | $3,684.42 |
DisclosureSEC source: 0001214659-25-004495 · marketforms-68763.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,892 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 277 | $40.91 | $11,332.90 |
DisclosureSEC source: 0001214659-25-004112 · marketforms-68685.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,984 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 526 | $44.18 | $23,237.10 |
DisclosureSEC source: 0001214659-25-003438 · marketforms-68340.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,261 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 806 | $49.35 | $39,777.71 |
DisclosureSEC source: 0001214659-25-002006 · marketforms-67966.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,221 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 144 | $45.59 | $6,565.12 |
DisclosureSEC source: 0001214659-25-000310 · marketforms-67750.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,027 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 316 | $44.90 | $14,189.35 |
DisclosureSEC source: 0001214659-24-020963 · marketforms-67656.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,171 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 133 | $46.81 | $6,225.33 |
DisclosureSEC source: 0001214659-24-020688 · marketforms-67608.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,487 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 367 | $52.70 | $19,342.37 |
DisclosureSEC source: 0001214659-24-020173 · marketforms-67532.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,620 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 22,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-020029 · marketforms-67498.xml · nonDerivative · entry 1 Cho Dennis · CIK 0001883451 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,987 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.